Cross-national inequalities and public health policy effects of the global retinoblastoma burden from 1990 to 2021 and projections to 2035
The study reveals that the global burden of RB is generally in a downward trend; however, low SDI regions continue to bear a disproportionately higher burden, underscoring persistent health inequalities. Policy improvement plays a key role in reducing the burden of disease. To further narrow regional disparities and reduce the overall burden, policy building needs to be strengthened globally, particularly in underdeveloped areas. The findings of this study may also provide valuable references for the prevention and treatment of other rare diseases and the promotion of health equity.
Authors
- Yu Wu (ORCID: https://orcid.org/0000-0003-0139-8105)
- Binwei Yu
- Wei Shao (ORCID: https://orcid.org/0000-0002-8594-0522)
- Na Zhou (ORCID: https://orcid.org/0000-0001-5768-8676)
- Ni Yuan
- Yaqun Wang
- Ji Luo
- Hanxiang Chen
- Min Li
Institutions
- King University (US)
- Jiamusi University (CN)
- Dalian Medical University (CN)
- Peking University (CN)
- Southwestern University of Finance and Economics (CN)
- Wuhan University (CN)
- Wuhan Donghu University (CN)
- Institute of Economic and Social Development (AR)
- First Hospital of China Medical University (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-01-26
- DOI
- https://doi.org/10.3389/fpubh.2026.1753390
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00